Aspire BioPharma, Inc. is trading 5.4% down at $6.02 today as the stock pulls back following a sharp multi-day rally.
- The move appears to be driven by profit-taking in the volatile name, with no fresh company-specific news or analyst downgrades identified so far.
- The downward pressure is stock-specific, as the broader market is currently trading higher, suggesting the move is not macro-driven.